Petros Pharmaceuticals Inc (PTPI) — Cash Flow Reinvestment Rate
Petros Pharmaceuticals Inc (PTPI) has a Cash Flow Reinvestment Rate of 0.01x as of December 2024, reinvesting $10.90K (capex $5.45K plus investments $-5.45K) from operating cash flow of $965.40K. Check PTPI cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Petros Pharmaceuticals Inc Cash Flow Reinvestment Rate (2018–2019)
Historical reinvestment intensity for Petros Pharmaceuticals Inc across 2 annual periods. Explore how well can Petros Pharmaceuticals Inc service its debt to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Petros Pharmaceuticals Inc (2018–2019)
Year-by-year capital reinvestment analysis for Petros Pharmaceuticals Inc. For live market cap and broader valuation context, see Petros Pharmaceuticals Inc (PTPI) market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2019 | 0.06x | $143.08K | $2.53 Million | $71.54K | ▼ -75.8% |
| 2018 | 0.23x | $1.88 Million | $8.02 Million | $1.88 Million | — |